Paper32408522
Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.
Marques IP and 6 others. J Clin Med, 2020. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy. Papers, record 32408522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32408522
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Retinopathy Phenotypes in Type 2 Diabetes with Different Risks for Macular Edema and Proliferative Retinopathy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FITEC/CIT/2018/2 | Programa Operacional Temático Factores de Competitividade | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07417410 | Analysis of DR Progression to Identify Risks and Need for Treatment | Background |
Source ClinicalTrials.gov
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32200833 | Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs - An Extension of the Modified Airlie House Classification: ETDRS Report Number 10. | Ophthalmology | 2020 | https://conductscience.org/library/papers/32200833 | PubMed |
| 2 | 2866759 | Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. | Arch Ophthalmol | 1985 | https://conductscience.org/library/papers/2866759 | PubMed |
| 3 | 25602634 | Topical nepafenec in eyes with noncentral diabetic macular edema. | Retina | 2015 | https://conductscience.org/library/papers/25602634 | PubMed |
| 4 | 26322834 | Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2. | Invest Ophthalmol Vis Sci | 2015 | https://conductscience.org/library/papers/26322834 | PubMed |
| 5 | 24680929 | Phenotypes and biomarkers of diabetic retinopathy. | Prog Retin Eye Res | 2014 | https://conductscience.org/library/papers/24680929 | PubMed |
| 6 | 16936162 | Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. | Diabetes Care | 2006 | https://conductscience.org/library/papers/16936162 | PubMed |
| 7 | 32181799 | Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/32181799 | PubMed |
| 8 | 29699981 | Microaneurysm turnover is a predictor of diabetic retinopathy progression. | Br J Ophthalmol | 2019 | https://conductscience.org/library/papers/29699981 | PubMed |
| 9 | 23745006 | Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23745006 | PubMed |
| 10 | 23841106 | Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations. | J Diabetes Res | 2013 | https://conductscience.org/library/papers/23841106 | PubMed |
| 11 | 31047568 | Agreement between OCT Leakage and Fluorescein Angiography to Identify Sites of Alteration of the Blood-Retinal Barrier in Diabetes. | Ophthalmol Retina | 2017 | https://conductscience.org/library/papers/31047568 | PubMed |
| 12 | 20580421 | Diabetic retinopathy. | Lancet | 2010 | https://conductscience.org/library/papers/20580421 | PubMed |
| 13 | 14769598 | Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. | Arch Ophthalmol | 2004 | https://conductscience.org/library/papers/14769598 | PubMed |
| 14 | 16965491 | The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. | Acta Ophthalmol Scand | 2006 | https://conductscience.org/library/papers/16965491 | PubMed |
| 15 | 29268280 | Different Phenotypes of Mild Nonproliferative Diabetic Retinopathy with Different Risks for Development of Macular Edema (C-TRACER Study). | Ophthalmic Res | 2018 | https://conductscience.org/library/papers/29268280 | PubMed |
| 16 | 21865671 | Improved automated screening of diabetic retinopathy. | Ophthalmologica | 2011 | https://conductscience.org/library/papers/21865671 | PubMed |
| 17 | 30389750 | Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial. | Diabetes | 2019 | https://conductscience.org/library/papers/30389750 | PubMed |
| 18 | 24080704 | Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes. | Ophthalmologica | 2013 | https://conductscience.org/library/papers/24080704 | PubMed |
| 19 | 23204247 | Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. | Diabetes Care | 2013 | https://conductscience.org/library/papers/23204247 | PubMed |
| 20 | 8628551 | Standardizing the measurement of visual acuity for clinical research studies: Guidelines from the Eye Care Technology Forum. | Ophthalmology | 1996 | https://conductscience.org/library/papers/8628551 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40646245 | Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging. | Eye (Lond) | 2025 | https://conductscience.org/library/papers/40646245 | PubMed |
| 37959396 | Immune Mediators Profiles in the Aqueous Humor of Patients with Simple Diabetic Retinopathy. | J Clin Med | 2023 | https://conductscience.org/library/papers/37959396 | PubMed |
| 37082811 | DNA methyltransferase expression (DNMT1, DNMT3a and DNMT3b) as a potential biomarker for anti-VEGF diabetic macular edema response. | Eur J Ophthalmol | 2023 | https://conductscience.org/library/papers/37082811 | PubMed |
| 36495395 | Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study. | Ophthalmol Ther | 2023 | https://conductscience.org/library/papers/36495395 | PubMed |
| 35757010 | Retinal Neurodegeneration in Different Risk Phenotypes of Diabetic Retinal Disease. | Front Neurosci | 2021 | https://conductscience.org/library/papers/35757010 | PubMed |
| 35450182 | A new handheld fundus camera combined with visual artificial intelligence facilitates diabetic retinopathy screening. | Int J Ophthalmol | 2022 | https://conductscience.org/library/papers/35450182 | PubMed |
| 35158351 | Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study. | Ophthalmologica | 2022 | https://conductscience.org/library/papers/35158351 | PubMed |
| 34900835 | The role of Optical Coherence Tomography Angiography to detect early microvascular changes in Diabetic Retinopathy: a systematic review. | J Diabetes Metab Disord | 2021 | https://conductscience.org/library/papers/34900835 | PubMed |
| 34865186 | Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy. | Ophthalmol Ther | 2022 | https://conductscience.org/library/papers/34865186 | PubMed |
| 34442470 | Characterization of Risk Profiles for Diabetic Retinopathy Progression. | J Pers Med | 2021 | https://conductscience.org/library/papers/34442470 | PubMed |
| 34442032 | Outcomes of Diabetic Retinopathy Post-Bariatric Surgery in Patients with Type 2 Diabetes Mellitus. | J Clin Med | 2021 | https://conductscience.org/library/papers/34442032 | PubMed |
| 34070479 | Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study. | J Clin Med | 2021 | https://conductscience.org/library/papers/34070479 | PubMed |
| 34063514 | Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study. | J Clin Med | 2021 | https://conductscience.org/library/papers/34063514 | PubMed |
| 33355147 | Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR. | Br J Ophthalmol | 2022 | https://conductscience.org/library/papers/33355147 | PubMed |
| 33158947 | Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study. | Diabetes Care | 2021 | https://conductscience.org/library/papers/33158947 | PubMed |
| 33025221 | Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression. | Acta Diabetol | 2021 | https://conductscience.org/library/papers/33025221 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GMCL1 | 64395 | PubTator's text mining | https://conductscience.org/library/genes/64395 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32408522
GET https://conductscience.org/api/papers/v1/32408522/references?page=2